| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $26.96 ▼ -0.71% | Yesterday | $27.23 ▲ +0.30% | Tomorrow's Anbio Biotechnology Class A Ordinary Shares (NNNN) setup is anchored to $27.15 and targets $26.96 (-0.71%). The near-term read is downside; watch $27.96 / $26.34 because daily realized volatility is about 3.65%. |
Tomorrow's Anbio Biotechnology Class A Ordinary Shares (NNNN) setup is anchored to $27.15 and targets $26.96 (-0.71%). The near-term read is downside; watch $27.96 / $26.34 because daily realized volatility is about 3.65%. | ||||
| Week | $26.55 ▼ -2.20% | Last Week | $27.40 ▲ +0.92% | The 7-day Anbio Biotechnology Class A Ordinary Shares model moves from $27.40 to $26.55 (-2.20%). It gives downside momentum context for this stock, so breaks around $27.96 / $26.34 matter more than a single tick. |
The 7-day Anbio Biotechnology Class A Ordinary Shares model moves from $27.40 to $26.55 (-2.20%). It gives downside momentum context for this stock, so breaks around $27.96 / $26.34 matter more than a single tick. | ||||
| Month | $25.88 ▼ -4.69% | Last Month | $27.68 ▲ +1.97% | The 1-month Anbio Biotechnology Class A Ordinary Shares target is $25.88 (-4.69%), compared with the live reference near $27.15. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Anbio Biotechnology Class A Ordinary Shares target is $25.88 (-4.69%), compared with the live reference near $27.15. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $24.87 ▼ -8.41% | Last Year | $28.11 ▲ +3.53% | The 1-year Anbio Biotechnology Class A Ordinary Shares scenario points to $24.87 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Anbio Biotechnology Class A Ordinary Shares scenario points to $24.87 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $22.50 ▼ -17.14% | 5 Years Ago | $29.10 ▲ +7.20% | The 5-year Anbio Biotechnology Class A Ordinary Shares view is $22.50 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Anbio Biotechnology Class A Ordinary Shares view is $22.50 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $27.15 | Mid |
| Daily Change | +0.63% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 58% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $27.15 | Daily Change | +0.63% |
| Market Cap | $3.91B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.